Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Harrington

Showing results (381-390 of 453) with videos related to

Pageof 46
Sort By:
Journal of Alzheimer'S Disease : JAD|January 18, 2021
Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial DegenerationAlejandra Martínez-Maldonado, Miguel Ángel Ontiveros-Torres, Charles R Harrington, et al.
Journal of Alzheimer'S Disease : JAD|June 23, 2020
National Dementia BioBank: A Strategy for the Diagnosis and Study of Neurodegenerative Diseases in MéxicoAldelmo Emmanuel Reyes-Pablo, B Berenice Campa-Córdoba, Nabil Itzi Luna-Viramontes, et al.
The Journal of Clinical Investigation|February 23, 2023
Nutrient regulation of the islet epigenome controls adaptive insulin secretionMatthew Wortham, Fenfen Liu, Austin R Harrington, et al.
Journal of Alzheimer'S Disease : JAD|April 14, 2020
Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal DementiaHelen Shiells, Bjoern O Schelter, Peter Bentham, et al.
Journal of Alzheimer'S Disease : JAD|November 21, 2017
Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical TrialGordon K Wilcock, Serge Gauthier, Giovanni B Frisoni, et al.
Journal of the American Chemical Society|June 25, 2020
Bicelles Rich in both Sphingolipids and Cholesterol and Their Use in Studies of Membrane ProteinsJames M Hutchison, Kuo-Chih Shih, Holger A Scheidt, et al.
Journal of Diabetes Science and Technology|March 28, 2022
Long-term Continuous Glucose Monitor Use in Very Young Children With Type 1 Diabetes: One-Year Results From the SENCE StudyMichelle A Van Name, Lauren G Kanapka, Linda A DiMeglio, et al.
The Journal of Prevention of Alzheimer'S Disease|April 18, 2026
Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control dataBjoern O Schelter, Helen Shiells, Serena Lo, et al.
Genome Biology|January 22, 2025
MaveDB 2024: a curated community database with over seven million variant effects from multiplexed functional assaysAlan F Rubin, Jeremy Stone, Aisha Haley Bianchi, et al.
The Journal of Prevention of Alzheimer'S Disease|January 22, 2026
Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's diseaseClaude M Wischik, Richard Stefanacci, Peter Bentham, et al.
Pageof 46

Showing results (381-390 of 453) with videos related to

Sort By:
Pageof 46
Journal of Alzheimer'S Disease : JAD|January 18, 2021
Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial DegenerationAlejandra Martínez-Maldonado, Miguel Ángel Ontiveros-Torres, Charles R Harrington, et al.
Journal of Alzheimer'S Disease : JAD|June 23, 2020
National Dementia BioBank: A Strategy for the Diagnosis and Study of Neurodegenerative Diseases in MéxicoAldelmo Emmanuel Reyes-Pablo, B Berenice Campa-Córdoba, Nabil Itzi Luna-Viramontes, et al.
The Journal of Clinical Investigation|February 23, 2023
Nutrient regulation of the islet epigenome controls adaptive insulin secretionMatthew Wortham, Fenfen Liu, Austin R Harrington, et al.
Journal of Alzheimer'S Disease : JAD|April 14, 2020
Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal DementiaHelen Shiells, Bjoern O Schelter, Peter Bentham, et al.
Journal of Alzheimer'S Disease : JAD|November 21, 2017
Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical TrialGordon K Wilcock, Serge Gauthier, Giovanni B Frisoni, et al.
Journal of the American Chemical Society|June 25, 2020
Bicelles Rich in both Sphingolipids and Cholesterol and Their Use in Studies of Membrane ProteinsJames M Hutchison, Kuo-Chih Shih, Holger A Scheidt, et al.
Journal of Diabetes Science and Technology|March 28, 2022
Long-term Continuous Glucose Monitor Use in Very Young Children With Type 1 Diabetes: One-Year Results From the SENCE StudyMichelle A Van Name, Lauren G Kanapka, Linda A DiMeglio, et al.
The Journal of Prevention of Alzheimer'S Disease|April 18, 2026
Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control dataBjoern O Schelter, Helen Shiells, Serena Lo, et al.
Genome Biology|January 22, 2025
MaveDB 2024: a curated community database with over seven million variant effects from multiplexed functional assaysAlan F Rubin, Jeremy Stone, Aisha Haley Bianchi, et al.
The Journal of Prevention of Alzheimer'S Disease|January 22, 2026
Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's diseaseClaude M Wischik, Richard Stefanacci, Peter Bentham, et al.
Pageof 46